The forecasted data for tuberculosis prevalence in the US from 2024 to 2028 illustrates a decreasing trend. Starting at 1.3 cases per hundred thousand persons in 2024, the prevalence is projected to decline to 0.4 by 2028. Between 2023 and 2024, there is an expected reduction, and the following years show consistent percentages of decrease: -15.4% from 2024 to 2025, -18.2% from 2025 to 2026, -33.3% from 2026 to 2027, and -33.3% from 2027 to 2028. The Compound Annual Growth Rate (CAGR) over this period is significantly negative, indicating a strong downward trend in tuberculosis cases.
Future trends to watch for include advancing treatment methods, emerging public health initiatives, and unforeseen factors like new tuberculosis strains or socio-economic changes that could alter the trajectory of these forecasts. Continuous monitoring will be vital to understand and predict deviations from these anticipated trends.
